11 found
Order:
Disambiguations
Patricia A. King [9]Patricia King [4]
  1.  18
    The Dangers of Difference.Patricia A. King - 1992 - Hastings Center Report 22 (6):35-38.
  2.  90
    Public Stem Cell Banks: Considerations of Justice in Stem Cell Research and Therapy.Ruth R. Faden, Liza Dawson, Alison S. Bateman-House, Dawn Mueller Agnew, Hilary Bok, Dan W. Brock, Aravinda Chakravarti, Xiao-Jiang Gao, Mark Greene, John A. Hansen, Patricia A. King, Stephen J. O'Brien, David H. Sachs, Kathryn E. Schill, Andrew Siegel, Davor Solter, Sonia M. Suter, Catherine M. Verfaillie, LeRoy B. Walters & John D. Gearhart - 2003 - Hastings Center Report 33 (6):13-27.
    If stem cell-based therapies are developed, we will likely confront a difficult problem of justice: for biological reasons alone, the new therapies might benefit only a limited range of patients. In fact, they might benefit primarily white Americans, thereby exacerbating long-standing differences in health and health care.
    Direct download (3 more)  
     
    Export citation  
     
    Bookmark   11 citations  
  3.  44
    Safety Issues In Cell-Based Intervention Trials.Liza Dawson, Alison S. Bateman-House, Dawn Mueller Agnew, Hilary Bok, Dan W. Brock, Aravinda Chakravarti, Mark Greene, Patricia King, Stephen J. O'Brien, David H. Sachs, Kathryn E. Schill, Andrew Siegel & Davor Solter - 2003 - Fertility and Sterility 80 (5):1077-1085.
    We report on the deliberations of an interdisciplinary group of experts in science, law, and philosophy who convened to discuss novel ethical and policy challenges in stem cell research. In this report we discuss the ethical and policy implications of safety concerns in the transition from basic laboratory research to clinical applications of cell-based therapies derived from stem cells. Although many features of this transition from lab to clinic are common to other therapies, three aspects of stem cell biology pose (...)
    Direct download  
     
    Export citation  
     
    Bookmark   4 citations  
  4.  50
    Harms of Excluding Pregnant Women from Clinical Research: The Case of HIV-Infected Pregnant Women.Nancy E. Kass, Holly A. Taylor & Patricia A. King - 1996 - Journal of Law, Medicine and Ethics 24 (1):36-46.
    Since the beginning of the AIDS epidemic, the proportion of AIDS cases among women has continued to rise. Women constituted 23 percent of the AIDS cases reported to the Centers for Disease Control and Prevention in 1995, and 81 percent of these women were of childbearing age. It was not until 1991, however, that epidemiological studies of women were initiated. By comparison, the representation of HIV-infected women in clinical trials gradually has grown. Undoubtedly, a consequence of the increased numbers of (...)
    Direct download (2 more)  
     
    Export citation  
     
    Bookmark   4 citations  
  5.  15
    Harms of excluding Pregnant Women from Clinical Research: The Case of HIV-Infected Pregnant Women.Nancy E. Kass, Holly A. Taylor & Patricia A. King - 1996 - Journal of Law, Medicine and Ethics 24 (1):36-46.
    Since the beginning of the AIDS epidemic, the proportion of AIDS cases among women has continued to rise. Women constituted 23 percent of the AIDS cases reported to the Centers for Disease Control and Prevention in 1995, and 81 percent of these women were of childbearing age. It was not until 1991, however, that epidemiological studies of women were initiated. By comparison, the representation of HIV-infected women in clinical trials gradually has grown. Undoubtedly, a consequence of the increased numbers of (...)
    Direct download (2 more)  
     
    Export citation  
     
    Bookmark   4 citations  
  6. Public Stem Cell Banks.Hilary Bok Mueller Agnew, Danw Brock, Aravinda Chakravarti, Xiao-Jiang Gao, Mark Greene, John A. Hansen, Patricia A. King, Stephen J. O'brien, David H. Sachs & Kathryn E. Schill - 2003 - Hastings Center Report 33 (6):13-27.
     
    Export citation  
     
    Bookmark  
  7.  18
    JME Referees in 1992.Barbara Applebaum, Lyn Brown, Don Cochrane, Mike Cross, Deborah Deemer, Janet Edwards, Ruth Hayhoe, Marilyn Johnson, Patricia King & Romulo Magsino - 1993 - Journal of Moral Education 22 (2):183.
    Direct download  
     
    Export citation  
     
    Bookmark  
  8.  8
    Commentary: Credibility, persuasiveness, and effectiveness.Patricia A. King - 1996 - Kennedy Institute of Ethics Journal 6 (3):313-317.
    In lieu of an abstract, here is a brief excerpt of the content:Credibility, Persuasiveness, and EffectivenessPatricia A. King (bio)Since the early 1970s, complex ethical, social, legal, and scientific controversies generated by biomedicine have been referred to governmentally created commissions, committees, boards, and panels that are commonly referred to as “ethics” committees. The Advisory Committee on Human Radiation Experiments is the most recent example of such a group. Although it is too early to know the full impact of the Committee’s work, (...)
    Direct download (4 more)  
     
    Export citation  
     
    Bookmark  
  9.  14
    Protecting Human Subjects: Do IRBs Do the Job?Patricia A. King, Karen Lebacaz & Michael S. Yesky - 1979 - Hastings Center Report 9 (3):4.
    Direct download (2 more)  
     
    Export citation  
     
    Bookmark  
  10.  12
    The Authority of Families to Make Medical Decisions for Incompetent Patients after the Cruzan Decision.Patricia A. King - 1991 - Journal of Law, Medicine and Ethics 19 (1-2):76-79.
    Direct download  
     
    Export citation  
     
    Bookmark   1 citation  
  11.  18
    The Authority of Families to Make Medical Decisions for Incompetent Patients after the Cruzan Decision.Patricia A. King - 1991 - Journal of Law, Medicine and Ethics 19 (1-2):76-79.
    Direct download (2 more)  
     
    Export citation  
     
    Bookmark